default author photo

David Vizcaya

Bayer Pharmaceuticals

SCHOLARLY PAPERS

1

DOWNLOADS

71

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Comparative Risks of Leukopenia, Pancytopenia, Infections, Cardiovascular Events, and Malignancy with First Line Conventional Synthetic Disease-Modifying Antirheumatic Drugs (CsDMARDs) in Rheumatoid Arthritis: An International Multinational Network Cohort Study

Number of pages: 20 Posted: 09 Dec 2022
Janssen Research & Development, LLC, University of Oxford - Rheumatology and Musculoskeletal Sciences, Universidade de Aveiro, InMusc, AbbVie Inc., Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Sanofi Aventis Group, The University of Manchester, National Institute for Health and Clinical Excellence (NHS), University of Tartu - Institute of Computer Science, National Institute for Health Development (Tallinn), University of Oxford, Institut de Recherches Servier, IQVIA - Real World Solutions, IQVIA - Real World Solutions, University of Oxford - Rheumatology and Musculoskeletal Sciences, University of Oxford, University of Tartu - Institute of Computer Science, Erasmus University Medical Center - Department of Medical Informatics, AbbVie Inc., Janssen Research & Development, LLC, Janssen Research & Development, LLC, Erasmus University Rotterdam (EUR) - Erasmus Medical Center (MC), Bayer Pharmaceuticals, Erasmus University Rotterdam (EUR) - Erasmus Medical Center (MC), Erasmus University Rotterdam (EUR) - Erasmus Medical Center (MC), Janssen Research & Development, LLC and University of Oxford - Rheumatology and Musculoskeletal Sciences
Downloads 71 (867,774)

Abstract:

Loading...